Published May 20, 2021 | Version v1
Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity
- 1. Janssen Pharmaceutica NV
This report describes the most relevant results of screening a drug repurposing library consisting of ~5500 FDA-approved drugs and clinical candidates that have passed phase I studies for activity against SARS-CoV-2.